Search:
« Stress can make women infertile
Why is it so hard to store your baby’s ‘life-saving’ stem cells? »

No-Drug, Anti-Inflammatory Diet Yields Positive Clinical-Trial Results, Including Marked Improvement Of Metabolic Abnormalities And Rapid Weight Loss

Research about the benefits of ano-drug, anti-inflammatory, and non-special dietary supplements diet is tobe presented June 24-27 at the 2006 annual Endocrine Society’s ScientificMeeting in Boston. The research’s author is Frank K. Leung, M.D., a fellow of the AmericanCollege of Endocrinology, and a Harvard-trained, board-certified physicianwith more than 20 years of experience in weight-reduction management anddiabetes treatment. [click link for full article]

More: continued here

This entry was posted on Tuesday, June 20th, 2006 at 10:06 am and is filed under Obesity. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply
Sign Up for a free account or learn more.
Submit Articles
Member Login
Top Authors
Most Popular Articles
Submission Guidelines
Ezine Notifications
Article RSS Feeds
About Us
Link to Us
Contact Us
Privacy Policy
Terms of Service
Sponsored Links
center>
Resources
Diet Sites
Food Information
Diet Pills
Fitness Resources
Health Help
Women's Links
Men's Links

Powered by Article Dashboard

Related News


  • VIVUS Announces Positive Phase 2 Clinical Trial Results With Qnexa, A Novel Therapy To Treat Obesity
    VIVUS, Inc.(Nasdaq: VVUS) today announced positive results from a 200-patient,double-blind, placebo-controlled clinical trial of Qnexa(TM), aninvestigational oral treatment for obesity. In the study conducted by DukeUniversity Medical Center, more than 50% of obese patients in the Qnexatreatment group experienced 10% or more total body weight loss during the24-week study period. Mean weight loss on an intent-to-treat (ITT) basis inthe Qnexa group was 25.1 lbs., compared to 4. [click link for full article]


  • Get Slim With A Little Help From Your Friend
    Reaching for that gallon of icecream? Reach for your computer mouse instead and do what many successfuldieters do to stick to their diet plan: buddy up to slim down. Clinical studies show getting social support by "Buddying Up" increasesweight loss success by encouraging dieters to stick to their diet andlifestyle improvement plans. More and more dieters are finding their BuddySupport network online at newly launched BuddySlim. [click link for full article]


  • Positive Results From A Phase IIa Study Of S-2367, A Novel Neuropeptide Y5 Receptor Antagonist For The Treatment Of Obesity
    Shionogi & Co, Ltd. today announced positive top-line efficacy results from a Phase IIa proof-of-concept trial with S-2367, an internally discovered drug candidate for obesity and related conditions. The unique mechanism of action of S-2367 involves blocking receptor binding of neuropeptide Y (NPY), a neurotransmitter involved in regulation of energy balance and food consumption. [click link for full article]


  • OREXIGEN(TM) Therapeutics To Present First Clinical Results For Contrave(TM) To Treat Obesity
    OREXIGEN(TM) Therapeutics, Inc., aprivately held clinical-stage neuroscience company developing a novelstrategic approach to the treatment of obesity, today announced that thecompany's lead program, Contrave(TM), has shown positive results in PhaseII clinical studies and is now being assessed in Phase III trials. Contraveand a companion clinical program Excalia(TM) are rationally formulated,proprietary combinations of marketed CNS products. [click link for full article]


  • Postcode lottery fears over new cancer drug
    A new 'wonder drug' for breast cancer could save the lives of 1,000 women a year, stunning trial results have shown. Aromasin has been hailed as 'excellent news for women' but there are fears that a combination of cost and red tape may mean many are denied the drug